Related references
Note: Only part of the references are listed.Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells
Anastasia Brooks et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
A STANDARDIZED AND CHARACTERIZED CLINICAL GRADE HUMAN PLATELET LYSATE FOR EFFICIENT EXPANSION OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS
S. Viau et al.
CYTOTHERAPY (2018)
Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells
Sabrina Viau et al.
PLOS ONE (2017)
Clinical Trials With Mesenchymal Stem Cells: An Update
Tiziana Squillaro et al.
CELL TRANSPLANTATION (2016)
Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture
Sandra Mjoll Jonsdottir-Buch et al.
CELL TRANSPLANTATION (2015)
Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion
Daniel Tzu-Bi Shih et al.
NEW BIOTECHNOLOGY (2015)
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions
Sarah M. Drawz et al.
TRANSFUSION (2015)
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
Sara Castiglia et al.
CYTOTHERAPY (2014)
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells
Paola Iudicone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Pathogen Inactivation Technologies for Cellular Blood Components: an Update
Peter Schlenke
TRANSFUSION MEDICINE AND HEMOTHERAPY (2014)
Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma
S. Y. Kwon et al.
VOX SANGUINIS (2014)
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components
Natalie Fekete et al.
CYTOTHERAPY (2012)
New insights on translational development of mesenchymal stromal cells for suppressor therapy
Moira Francois et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Gamma irradiation of animal sera for inactivation of viruses and mollicutes - A review
Raymond W. Nims et al.
BIOLOGICALS (2011)
Pathogen-inactivation of platelet components with the INTERCEPT Blood System™: A cohort study
Laura Infanti et al.
TRANSFUSION AND APHERESIS SCIENCE (2011)
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
J. -P Cazenave et al.
TRANSFUSION (2010)
Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow
Karen Bieback et al.
STEM CELLS (2009)
A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light
Harald Mohr et al.
TRANSFUSION (2009)
Solvent/detergent treatment of platelet concentrates enhances the release of growth factors
Thierry Burnouf et al.
TRANSFUSION (2008)
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells
Bruno Delorme et al.
BLOOD (2008)
The in vitro migration capacity of human bone marrow mesenchymal stem cells:: Comparison of chemokine and growth factor chemotactic activities
Adriana Lopez Ponte et al.
STEM CELLS (2007)
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute
M. E. Bernardo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
The Mirasol TM PRT system for pathogen reduction of platelets and plasma:: An overview of current status and future trends
Raymond P. Goodrich et al.
TRANSFUSION AND APHERESIS SCIENCE (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
The concept of mesenchymal stem cells
Bruno Delorme et al.
REGENERATIVE MEDICINE (2006)
Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications
C Doucet et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy
JL Spees et al.
MOLECULAR THERAPY (2004)
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment:: the euroSPRITE trial
D van Rhenen et al.
BLOOD (2003)
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
EM Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets
V Ciaravino et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2001)
Share Paper
